id: NEW:biomarker_feedback_intervention_to_NEW:gamma_glutamyl_transferase_levels
name: Biomarker-Based Feedback Intervention for Alcohol Use â†’ Gamma-Glutamyl Transferase (GGT) Levels
from_node:
  node_id: NEW:biomarker_feedback_intervention
  node_name: Biomarker-Based Feedback Intervention for Alcohol Use
to_node:
  node_id: NEW:gamma_glutamyl_transferase_levels
  node_name: Gamma-Glutamyl Transferase (GGT) Levels
direction: negative
category: biological
mechanism_pathway:
- 'Step 1: Biomarker-based advice is integrated into routine alcohol care'
- 'Step 2: Patients receive personalized feedback showing elevated GGT indicating liver injury'
- 'Step 3: Reduced alcohol consumption following intervention decreases ongoing hepatocellular damage'
- 'Step 4: Liver enzyme levels normalize as hepatocyte injury decreases'
- 'Step 5: Measurable reduction in serum GGT levels indicates improved liver health'
evidence:
  quality_rating: A
  n_studies: 16
  primary_citation: 'Mohsan Subhani et al. 2021. "Does Advice Based on Biomarkers of Liver Injury or Non-Invasive
    Tests of Liver Fibrosis Impact High-Risk Drinking Behaviour: A Systematic Review With Meta-analysis.."
    https://doi.org/10.1093/alcalc/agaa143'
  supporting_citations:
  - Studies included 14 randomized controlled trials and 2 observational studies (specific citations require
    full-text access)
  - Additional citations require full-text access for individual RCT details
  - Additional citations require full-text access for observational study details
  doi: 10.1093/alcalc/agaa143
  citation_verified: true
last_updated: '2025-12-06'
version: '2.0'
description: Biomarker-based intervention advice reduces GGT levels by 19.7 IU/l compared to control groups,
  indicating improved liver function as a biological marker of reduced alcohol-related harm.
quantitative_effects:
  effect_size:
    value: -19.7
    type: standardized_mean_difference
    ci_lower: -33.1
    ci_upper: -6.4
  p_value: 0.004
  sample_size: 3763
structural_competency:
  equity_implications: This biological mechanism demonstrates how healthcare system interventions can
    produce measurable improvements in organ function. The structural element is the healthcare delivery
    system's capacity to monitor and respond to biomarker changes, enabling early intervention before
    progression to severe liver disease.
llm_metadata:
  extracted_by: claude-opus-4-5-20251101
  extraction_date: '2025-12-06T21:12:37.016991'
  extraction_confidence: high
  prompt_version: 2.1-canonical-validated
